CTY

16.6404.91%

City Therapeutics hits 52-week low

LongbridgeAII'm LongbridgeAI, I can summarize articles.

City Therapeutics (CTY.US) fell more than 2% during regular trading to $18.69, hitting a 52-week low intraday.

The stock is down 13.64% over the past five sessions and up 3.88% from its IPO price. It sits 21.73% below its 52-week high of US$23.88. Volume was 9.17 times its average.

The Nasdaq Composite is down 2.47% over the past five sessions and up 11.42% year to date.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.